Anemia among HIV-infected patients initiating antiretroviral therapy in South Africa: Improvement in hemoglobin regardless of degree of immunosuppression and the initiating art regimen

Journal of Tropical Medicine

Volumn , Issue , 2013, Pages

  Takuva, Simbarashe ^a   Maskew, Mhairi ^a   Brennan, Alana T ^b   Sanne, Ian ^a   Macphail, A Patrick ^a   Fox, Mathew P ^a,b,c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; EFAVIRENZ; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; HEMOGLOBIN; NEVIRAPINE; STAVUDINE; ZIDOVUDINE;

ADULT; ANEMIA; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NATIONAL HEALTH ORGANIZATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SOUTH AFRICA; VIRUS LOAD;

EID: 84884278405     PISSN: 16879686     EISSN: 16879694     Source Type: Journal    
DOI: 10.1155/2013/162950     Document Type: Article

References (27)

1. Sullivan P. S., Hanson D. L., Chu S. Y., Jones J. L., Ward J. W., Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 1998 91 1 301 308 2-s2.0-0031975144
2. Moore R. D., Forney D., Anemia in HIV-infected patients receiving highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 2002 29 1 54 57 2-s2.0-0036151430
3. Mocroft A., Kirk O., Barton S. E., Dietrich M., Proenca R., Colebunders R., Pradier C., D'Arminio Monforte A., Ledergerber B., Lundgren J. D., Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. AIDS 1999 13 8 943 950 2-s2.0-20244375228 10.1097/00002030-199905280-00010
4. Lundgren J. D., Mocroft A., Gatell J. M., A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA Study. Journal of Infectious Diseases 2002 185 1 178 187 2-s2.0-0036642511
5. Moore R. D., Keruly J. C., Chaisson R. E., Anemia and survival in HIV infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1998 19 1 29 33 2-s2.0-0032168057
6. World Health Organization, Worldwide Prevalence of Anemia 1993-2005: WHO Global Database on Anemia 2008 Geneva, Switzerland WHO
7. Semba R. D., Gray G. E., Pathogenesis of anemia during human immunodeficiency virus infection. Journal of Investigative Medicine 2001 49 3 225 239 2-s2.0-0035000316
8. Johannessen A., Naman E., Gundersen S. G., Bruun J. N., Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania. BMC Infectious Diseases 2011 11, article 190 2-s2.0-79960034703 10.1186/1471-2334-11-190
9. Camacho J., Poveda F., Zamorano A. F., Valencia M. E., Vazquez J. J., Arnalich F., Serum erythropoietin levels in anaemic patients with advanced human immunodeficiency virus infection. British Journal of Haematology 1992 82 3 608 614 2-s2.0-0026472437
10. Moyle G., Sawyer W., Law M., Amin J., Hill A., Changes in hematologic parameters and efficacy of thymidine analogue based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies. Clinical Therapeutics 2004 26 1 92 97 2-s2.0-1242317090 10.1016/S0149-2918(04)90009-4
11. Jacobson M. A., Peiperl L., Volberding P. A., Porteous D., Toy P. T. C. Y., Feigal D., Red cell transfusion therapy for anemia in patients with AIDS and ARC: incidence, associated factors, and outcome. Transfusion 1990 30 2 133 137 2-s2.0-0025120333
12. Frickhofen N., Abkowitz J. L., Safford M., Berry J. M., Antunez-de-Mayolo J., Astrow A., Cohen R., Halperin I., King L., Mintzer D., Cohen B., Young N. S., Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Annals of Internal Medicine 1990 113 12 926 933 2-s2.0-0025685595
13. Northfelt D. W., Mayer A., Kaplan L. D., Abrams D. I., Hadley W. K., Yajko D. M., Herndier B. G., The usefulness of diagnostic bone marrow examination in patients with human immunodeficiency virus (HIV) infection. Journal of Acquired Immune Deficiency Syndromes 1991 4 7 659 666 2-s2.0-0026049822
14. McGinniss M. H., Macher A. M., Rook A. H., Alter H. J., Red cell autoantibodies in patients with acquired immune deficiency syndrome. Transfusion 1986 26 5 405 409 2-s2.0-0022982230
15. Kiragga A. N., Castelnuovo B., Nakanjako D., Manabe Y. C., Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings. Journal of the International AIDS Society 2010 13 1, article 42 2-s2.0-78049340819 10.1186/1758-2652-13-42
16. Ssali F., Stöhr W., Munderi P., Reid A., Walker A. S., Gibb D. M., Mugyenyi P., Kityo C., Grosskurth H., Hakim J., Byakwaga H., Katabira E., Derbyshire J. H., Gilks C. F., Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial. Antiviral Therapy 2006 11 6 741 749 2-s2.0-33749356252
17. Fox M. P., Maskew M., Macphail A. P., Cohort Profile: The Themba Lethu Clinical Cohort, Johannesburg, South Africa. International Journal of Epidemiology 2013 42 2 430 439 10.1093/ije/dys029
18. National Department of Health, Republic of South Africa, National Antiretroviral Treatment Guidelines 2004 Jacana
19. Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 1.0 2004 National Institutes of Health Division of AIDS
20. Hoffmann C. J., Fielding K. L., Charalambous S., Sulkowski M. S., Innes C., Thio C. L., Chaisson R. E., Churchyard G. J., Grant A. D., Antiretroviral therapy using zidovudine, lamivudine, and efavirenz in South Africa: tolerability and clinical events. AIDS 2008 22 1 67 74 2-s2.0-37349036173 10.1097/QAD.0b013e3282f2306e
21. Semba R. D., Shah N., Klein R. S., Maye K. H., Schuman P., Vlahov D., Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clinical Infectious Diseases 2002 34 2 260 266 2-s2.0-0037079841 10.1086/338151
22. Wills T. S., Nadler J. P., Somboonwit C., Vincent A., Leitz G., Marino K., Naik E., Powers S., Khan N., Laartz B., Anemia prevalence and associated risk factors in a single-center ambulatory HIV clinical cohort. AIDS Reader 2004 14 6 305 310 2-s2.0-3042642000
23. Zhou J., Jaquet A., Bissagnene E., Musick B., Wools-Kaloustian K., Maxwell N., Boulle A., Wehbe F., Masys D., Iriondo-Perez J., Hemingway-Foday J., Law M., Short-term risk of anaemia following initiation of combination antiretroviral treatment in HIV-infected patients in countries in sub-Saharan Africa, Asia-Pacific, and central and South America. Journal of the International AIDS Society 2012 15 1, article 5 2-s2.0-84856247393 10.1186/1758-2652-15-5
24. Takuva S., Louwagie G., Zuma K., Okello V., Durability of first line antiretroviral therapy: reasons and predictive factors for modifications in a Swaziland Cohort. Journal of Antivirals and Antiretrovirals 2012 4 1 14 20 2-s2.0-84857604296 10.4172/jaa.1000040
25. Subbaraman R., Chaguturu S. K., Mayer K. H., Flanigan T. P., Kumarasamy N., Adverse effects of highly active antiretroviral therapy in developing countries. Clinical Infectious Diseases 2007 45 8 1093 1101 2-s2.0-34848888307 10.1086/521150
26. Laurent C., Bourgeois A., Mpoudi-Ngolé E., Ciaffi L., Kouanfack C., Mougnutou R., Nkoué N., Calmy A., Koulla-Shiro S., Delaporte E., Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon. AIDS Research and Human Retroviruses 2008 24 supplement 3 393 399 2-s2.0-41449116953 10.1089/aid.2007.0219
27. Coetzee D., Hildebrand K., Boulle A., Maartens G., Louis F., Labatala V., Reuter H., Ntwana N., Goemaere E., Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004 18 6 887 895 2-s2.0-2142764446 10.1097/00002030-200404090-00006